FormulaFolio Investments LLC Buys Shares of 9,602 Cardinal Health, Inc. (NYSE:CAH)
FormulaFolio Investments LLC purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) in the fourth quarter, according to its most recent filing with the SEC. The fund purchased 9,602 shares of the company’s stock, valued at approximately $514,000.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Cambridge Financial Group Inc. increased its holdings in shares of Cardinal Health by 12.7% in the 4th quarter. Cambridge Financial Group Inc. now owns 121,852 shares of the company’s stock valued at $6,526,000 after acquiring an additional 13,740 shares during the last quarter. PDS Planning Inc bought a new stake in shares of Cardinal Health in the 4th quarter valued at approximately $278,000. Sivik Global Healthcare LLC bought a new position in Cardinal Health during the 4th quarter worth $5,356,000. Cubic Asset Management LLC grew its stake in Cardinal Health by 78.5% during the 4th quarter. Cubic Asset Management LLC now owns 14,785 shares of the company’s stock worth $792,000 after buying an additional 6,500 shares during the last quarter. Finally, NN Investment Partners Holdings N.V. grew its stake in Cardinal Health by 14.8% during the 4th quarter. NN Investment Partners Holdings N.V. now owns 39,546 shares of the company’s stock worth $2,118,000 after buying an additional 5,112 shares during the last quarter. Institutional investors and hedge funds own 82.62% of the company’s stock.
Shares of NYSE CAH opened at $60.70 on Thursday. Cardinal Health, Inc. has a 12 month low of $44.65 and a 12 month high of $62.96. The company has a market cap of $17.83 billion, a price-to-earnings ratio of 18.34, a P/E/G ratio of 1.75 and a beta of 1.03. The company has a quick ratio of 0.57, a current ratio of 1.13 and a debt-to-equity ratio of 4.72. The business has a fifty day simple moving average of $56.36 and a 200-day simple moving average of $53.35.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 15th. Investors of record on Thursday, April 1st will be given a dividend of $0.4859 per share. This represents a $1.94 annualized dividend and a yield of 3.20%. The ex-dividend date is Wednesday, March 31st. Cardinal Health’s payout ratio is 35.60%.
A number of research analysts recently commented on the company. TheStreet upgraded Cardinal Health from a “c” rating to a “b” rating in a research note on Friday, February 5th. Wolfe Research upgraded Cardinal Health from an “underperform” rating to a “peer perform” rating in a research report on Friday, January 8th. Finally, Morgan Stanley reduced their price target on Cardinal Health from $66.00 to $64.00 and set an “equal weight” rating for the company in a research report on Tuesday, March 9th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Cardinal Health presently has a consensus rating of “Buy” and a consensus price target of $60.10.
About Cardinal Health
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company operates through two segments, Pharmaceutical and Medical.
Recommended Story: What is a front-end load?
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.